EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Artesunate, EDTA, and colistin work synergistically against MCR-negative and -positive colistin-resistant Salmonella

Yajun Zhai iD, Peiyi Liu, Xueqin Hu, Changjian Fan, Xiaodie Cui, Qibiao He, Dandan He, Xiaoyuan Ma, Gongzheng Hu

eLife · 2025

DOI: 10.7554/elife.99130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Yajun Zhai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China. Hauptthemen laut MEDLINE: Colistin, Anti-Bacterial Agents, Artesunate, Edetic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Discovering new strategies to combat the multidrug-resistant bacteria constitutes a major medical challenge of our time. Previously, artesunate (AS) has been reported to exert antibacterial enhancement activity in combination with β-lactam antibiotics via inhibition of the efflux pump AcrB. However, combination of AS and colistin (COL) revealed a weak synergistic effect against a limited number of strains, and few studies have further explored its possible mechanism of synergistic action. In this article, we found that AS and EDTA could strikingly enhance the antibacterial effects of COL against mcr-1 - and mcr-1 + Salmonella strains either in vitro or in vivo, when used in triple combination. The excellent bacteriostatic effect was primarily related to the increased cell membrane damage, accumulation of toxic compounds and inhibition of MCR-1. The potential binding sites of AS to MCR-1 (THR283, SER284, and TYR287) were critical for its inhibition of MCR-1 activity. Additionally, we also demonstrated that the CheA of chemosensory system and virulence-related protein SpvD were critical for the bacteriostatic synergistic effects of the triple combination. Selectively targeting CheA, SpvD, or MCR using the natural compound AS could be further investigated as an attractive strategy for the treatment of Salmonella infection. Collectively, our work opens new avenues toward the potentiation of COL and reveals an alternative drug combination strategy to overcome COL-resistant bacterial infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColistinAnti-Bacterial AgentsArtesunateEdetic AcidSalmonellaDrug Resistance, BacterialDrug SynergismAnimalsMiceMicrobial Sensitivity TestsDrug Resistance, Multiple, Bacterial

Stichwörter der Autor:innen

S. enterica serovar typhiSalmonellacell biologycolistin resistanttriple combination

Substanzen

ColistinAnti-Bacterial AgentsArtesunateEdetic Acid

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.

ORCID-Profile: Yajun Zhai

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhai, Y., Liu, P., Hu, X., Fan, C., Cui, X., He, Q., He, D., Ma, X., & Hu, G. (2025). Artesunate, EDTA, and colistin work synergistically against MCR-negative and -positive colistin-resistant Salmonella. eLife. https://doi.org/10.7554/elife.99130

Vancouver

Zhai Y, Liu P, Hu X, Fan C, Cui X, He Q, et al. Artesunate, EDTA, and colistin work synergistically against MCR-negative and -positive colistin-resistant Salmonella. eLife. 2025. doi:10.7554/elife.99130

BibTeX
@article{Zhai2025,
  author = {Zhai, Yajun and Liu, Peiyi and Hu, Xueqin and Fan, Changjian and Cui, Xiaodie and He, Qibiao and He, Dandan and Ma, Xiaoyuan and Hu, Gongzheng},
  title = {Artesunate, EDTA, and colistin work synergistically against MCR-negative and -positive colistin-resistant Salmonella},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.99130}
}
Kostenlos starten →